View More
Download this PDF guide outlining key information on HCC risk assessment, screening, and surveillance in the setting of Hepatitis B infection
Expert CCO commentary on how to incorporate noninvasive methods to assess fibrosis into management of patients with HBV infection
Watch this brief presentation by Dr. Paul Kwo on interpreting serology, HBV DNA, and fibrosis assessments to determine HBV treatment candidacy.
Download free expert-authored slides reviewing AASLD guidance on HBV management pretreatment evaluation to determine treatment candidacy
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.